The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
Open accessAbstract
Using whole-cell phenotypic assays, the GlaxoSmithKline high-throughput screening (HTS) diversity set of 1.8 million compounds was screened against the three kinetoplastids most relevant to human disease, i.e. Leishmania donovani , Trypanosoma cruzi and Trypanosoma brucei . Secondary confirmatory and orthogonal intracellular anti-parasiticidal assays were conducted and the potential for non-specific cytotoxicity determined. Hit compounds were chemically clustered and triaged for desirable physicochemical properties. The hypothetical biological target space covered by these diversity sets was investigated through bioinformatics methodologies. Consequently, three anti-kinetoplastid chemical boxes of ~200 compounds each were assembled. Functional analyses of these compounds suggest a wide array of potential modes of action against kinetoplastid kinases, proteases and cytochromes as well as potential host–pathogen targets. This is the first published parallel high throughput screening of a pharma compound collection against kinetoplastids. The compound sets are provided as an open resource for future lead discovery programs and to address important research questions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst197 · Cited by 47,205
Jalview Version 2—a multiple sequence alignment editor and analysis workbench
Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M., & Barton, G. J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp033 · Cited by 10,235
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Data, information, knowledge and principle: back to metabolism in KEGG
Kanehisa, M., Goto, S., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1076 · Cited by 3,092
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Borst, O., Walker, B., Münzer, P., Russo, A., Schmid, E., Faggio, C., Bigalke, B., Laufer, S., Gawaz, M., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350110 · Cited by 1,860
The Genome of the African Trypanosome Trypanosoma brucei
Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G., Renauld, H., Bartholomeu, D. C., Lennard, N. J., Caler, E., Hamlin, N. E., Haas, B., et al. (2005) · Science · doi:10.1126/science.1112642 · Cited by 1,631
Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100008c · Cited by 1,063
TriTrypDB: a functional genomic resource for the Trypanosomatidae
Aslett, M., Aurrecoechea, C., Berriman, M., Brestelli, J., Brunk, B. P., Carrington, M., Depledge, D. P., Fischer, S., Gajria, B., Gao, X., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp851 · Cited by 986
Comparative Genomics of Trypanosomatid Parasitic Protozoa
El-Sayed, N. M., Myler, P. J., Blandin, G., Berriman, M., Crabtree, J., Aggarwal, G., Caler, E., Renauld, H., Worthey, E. A., Hertz-Fowler, C., et al. (2005) · Science · doi:10.1126/science.1112181 · Cited by 819
Kinetoplastids: related protozoan pathogens, different diseases
Stuart, K., Brun, R., Croft, S., Fairlamb, A., Gürtler, R. E., McKerrow, J., Reed, S., & Tarleton, R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33945 · Cited by 604
An Introduction To Chemoinformatics
Leach, A. R., & Gillet, V. J. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6291-9 · Cited by 533
Pursuing the leadlikeness concept in pharmaceutical research
Hann, M. M., & Oprea, T. I. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.003 · Cited by 515
Downing, T., Imamura, H., Decuypere, S., Clark, T. G., Coombs, G. H., Cotton, J. A., Hilley, J. D., de Doncker, S., Maes, I., Mottram, J. C., et al. (2011) · Genome Research · doi:10.1101/gr.123430.111 · Cited by 423
Parsons, M., Worthey, E. A., Ward, P. N., & Mottram, J. C. (2005) · BMC Genomics · doi:10.1186/1471-2164-6-127 · Cited by 358
The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment
Pedrique, B., Strub-Wourgaft, N., Some, C., Olliaro, P., Trouiller, P., Ford, N., Pécoul, B., & Bradol, J.-H. (2013) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70078-0 · Cited by 352
Young, R. J., Green, D. V. S., Luscombe, C. N., & Hill, A. P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.001 · Cited by 311
Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites
Hall, B. S., Bot, C., & Wilkinson, S. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.230847 · Cited by 262
Jones, N. G., Thomas, E. B., Brown, E., Dickens, N. J., Hammarton, T. C., & Mottram, J. C. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003886 · Cited by 184
Rycker, M. D., Hallyburton, I., Thomas, J. C., Campbell, L. A., Wyllie, S., Joshi, D., Cameron, S., Gilbert, I. H., Wyatt, P. G., Frearson, J. A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02398-12 · Cited by 160
Self-citationMechanism of Trypanosoma brucei gambiense resistance to human serum
Uzureau, P., Uzureau, S., Lecordier, L., Fontaine, F., Tebabi, P., Homblé, F., Grélard, A., Zhendre, V., Nolan, D. P., Lins, L., et al. (2013) · Nature · doi:10.1038/nature12516 · Cited by 159
Brown, J. R., Koretke, K. K., Birkeland, M. L., Sanséau, P., & Patrick, D. R. (2004) · BMC Evolutionary Biology · doi:10.1186/1471-2148-4-39 · Cited by 122
Self-citationTargeting Trypanosoma cruzi Sterol 14α-Demethylase (CYP51)
Lepesheva, G. I., Villalta, F., & Waterman, M. R. (2011) · Advances in Parasitology/Advances in parasitology · doi:10.1016/b978-0-12-385863-4.00004-6 · Cited by 121
Brown, J. R., & Auger, K. R. (2011) · BMC Evolutionary Biology · doi:10.1186/1471-2148-11-4 · Cited by 111
Self-citationBettiol, E., Samanovic, M. I., Murkin, A. S., Raper, J., C, F. S. B. A., & Rodríguez, A. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000384 · Cited by 91
Sykes, M. L., & Avery, V. M. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.09-0015 · Cited by 85
Hargrove, T. Y., Wawrzak, Z., Alexander, P. W., Chaplin, J. H., Keenan, M., Charman, S. A., Perez, C. J., Waterman, M. R., Chatelain, E., & Lepesheva, G. I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.497990 · Cited by 79
Aulner, N., Danckaert, A., Rouault, E., Desrivot, J., Helynck, O., Commère, P., Munier‐Lehmann, H., Späth, G. F., Shorte, S. L., Milon, G., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002154 · Cited by 77
A Nonazole CYP51 Inhibitor Cures Chagas’ Disease in a Mouse Model of Acute Infection
Doyle, P. S., Chen, C.-K., Johnston, J. B., Hopkins, S. D., Leung, S. S. F., Jacobson, M. P., Engel, J. C., McKerrow, J. H., & Podust, L. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00281-10 · Cited by 71
Alonso-Padilla, J., Cotillo, I., Presa, J. L., Cantizani, J., Peña, I., Bardera, A. I., Martin, J. J., & Rodríguez, A. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003493 · Cited by 67
Self-citationSeebeck, T., Sterk, G. J., & Ke, H. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.77 · Cited by 67
Activity of anti-cancer protein kinase inhibitors against Leishmania spp.
Sanderson, L., Yardley, V., & Croft, S. L. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku069 · Cited by 67
Andriani, G., Amata, E., Beatty, J. W., Clements, Z. T., Coffey, B. J., Courtemanche, G., Devine, W. G., Erath, J., Juda, C. E., Wawrzak, Z., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400012e · Cited by 66
Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51
Gunatilleke, S. S., Calvet, C. M., Johnston, J. B., Chen, C.-K., Erenburg, G., Gut, J., Engel, J. C., Ang, K. K. H., Mulvaney, J., Chen, S., et al. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001736 · Cited by 65
Gould, M. K., Bachmaier, S., Ali, J. A. M., Alsford, S., Tagoe, D. N. A., Munday, J. C., Schnaufer, A. C., Horn, D., Boshart, M., & de Koning, H. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00508-13 · Cited by 62
Kinetoplastid papain-like cysteine peptidases
Caffrey, C. R., & Steverding, D. (2009) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2009.04.009 · Cited by 59
Cummings, H., Barbi, J. J., Reville, P. K., Oghumu, S., Zorko, N. A., Sarkar, A., Keiser, T. L., Lu, B., Rückle, T., Varikuti, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110339109 · Cited by 53
Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery
Patel, G., Roncal, N. E., Lee, P. J., Leed, S. E., Erath, J., Rodrı́guez, A., Sciotti, R. J., & Pollastri, M. P. (2014) · MedChemComm · doi:10.1039/c4md00045e · Cited by 52
Wang, H., Kunz, S., Chen, G., Seebeck, T., Wan, Y., Robinson, H. H., Martinelli, S., & Ke, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.326777 · Cited by 32
Efficient Iron Uptake via a Reductive Mechanism in ProcyclicTrypanosoma brucei
Mach, J., Tachezy, J., & Šuťák, R. (2013) · Journal of Parasitology · doi:10.1645/ge-3237.1 · Cited by 19
Cited by
Hit and lead criteria in drug discovery for infectious diseases of the developing world
Katsuno, K., Burrows, J. N., Duncan, K., van Huijsduijnen, R. H., Kaneko, T., Kita, K., Mowbray, C. E., Schmatz, D., Warner, P., & Slingsby, B. T. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4683 · Cited by 607
Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery
Ekins, S., Lage de Siqueira-Neto, J., McCall, L.-I., Sarker, M., Yadav, M., Ponder, E. L., Kallel, E. A., Kellar, D., Chen, S., Arkin, M., et al. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0003878 · Cited by 93
Metadata
- Authors
- Peña, I., Pilar Manzano, M., Cantizani, J., Kessler, A., Alonso-Padilla, J., Bardera, A. I., Alvarez, E., Colmenarejo, G., Cotillo, I., Roquero, I., de Dios-Anton, F., Barroso, V., Rodriguez, A., Gray, D. W., Navarro, M., Kumar, V., Sherstnev, A., Drewry, D. H., Brown, J. R., Fiandor, J. M., & Julio Martin, J.
- Venue
- Scientific Reports
- Published
- 2015-03-05
- Volume
- 5
- Issue
- 1
- Pages
- 8771-8771
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2035555452
- Cited by
- 260
- References
- 43
- FWCI
- 30.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.